Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Unemo

Showing results (241-250 of 438) with videos related to

Pageof 44
Sort By:
Sexually Transmitted Infections|April 4, 2020
Call to action for health systems integration of point-of-care testing to mitigate the transmission and burden of sexually transmitted infectionsIgor Toskin, Veloshnee Govender, Karel Blondeel, et al.
International Journal of STD & AIDS|July 5, 2022
Unencapsulated penicillin-resistant <i>Neisseria meningitidis</i> ST-53 clonal complex strain causing symptomatic proctitis in an HIV-negative man who has sex with men: A case reportValeska Padovese, Sabrina Goodlip, Claire Marantidis Cordina, et al.
BMC Infectious Diseases|December 5, 2018
Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016Michaela J Day, Gianfranco Spiteri, Susanne Jacobsson, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2024
Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoeaMagnus Unemo, Daniel Golparian, Joakim Oxelbark, et al.
Microbiology Resource Announcements|February 1, 2024
Complete reference genomes of two ceftriaxone-resistant <i>Neisseria gonorrhoeae</i> strains identified in routine surveillance in Bangkok, Thailand, using Nanopore Q20+ chemistry, VolTRAX V2b, and Illumina sequencingPongsathorn Sangprasert, Daniel Golparian, Porntip Paopang, et al.
The Journal of Antimicrobial Chemotherapy|February 10, 2021
High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018Magnus Unemo, Josefine Ahlstrand, Leonor Sánchez-Busó, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 19, 2023
Single-dose cefixime 800 mg plus doxycycline 100 mg twice a day for 7 days compared with single-dose ceftriaxone 1 g plus single-dose azithromycin 2 g for treatment of urogenital, rectal, and pharyngeal gonorrhoea: a randomised clinical trialBeatrice Bížová, Přemysl Procházka, Elka Nyčová, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 14, 2017
Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011-2015Ronza Hadad, Daniel Golparian, Amaya C Lagos, et al.
Antimicrobial Agents and Chemotherapy|January 5, 2012
Clonally related Neisseria gonorrhoeae isolates with decreased susceptibility to the extended-spectrum cephalosporin cefotaxime in Amsterdam, the NetherlandsRaymond Heymans, Sylvia M Bruisten, Daniel Golparian, et al.
Journal of Global Antimicrobial Resistance|November 18, 2020
Gonorrhoea treatment combined with population-level general cephalosporin and quinolone consumption may select for Neisseria gonorrhoeae antimicrobial resistance at the levels of NG-MAST genogroup: An ecological study in EuropeChris Kenyon, Jolein Laumen, Christophe Van Dijck, et al.
Pageof 44

Showing results (241-250 of 438) with videos related to

Sort By:
Pageof 44
Sexually Transmitted Infections|April 4, 2020
Call to action for health systems integration of point-of-care testing to mitigate the transmission and burden of sexually transmitted infectionsIgor Toskin, Veloshnee Govender, Karel Blondeel, et al.
International Journal of STD & AIDS|July 5, 2022
Unencapsulated penicillin-resistant <i>Neisseria meningitidis</i> ST-53 clonal complex strain causing symptomatic proctitis in an HIV-negative man who has sex with men: A case reportValeska Padovese, Sabrina Goodlip, Claire Marantidis Cordina, et al.
BMC Infectious Diseases|December 5, 2018
Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016Michaela J Day, Gianfranco Spiteri, Susanne Jacobsson, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2024
Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoeaMagnus Unemo, Daniel Golparian, Joakim Oxelbark, et al.
Microbiology Resource Announcements|February 1, 2024
Complete reference genomes of two ceftriaxone-resistant <i>Neisseria gonorrhoeae</i> strains identified in routine surveillance in Bangkok, Thailand, using Nanopore Q20+ chemistry, VolTRAX V2b, and Illumina sequencingPongsathorn Sangprasert, Daniel Golparian, Porntip Paopang, et al.
The Journal of Antimicrobial Chemotherapy|February 10, 2021
High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018Magnus Unemo, Josefine Ahlstrand, Leonor Sánchez-Busó, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 19, 2023
Single-dose cefixime 800 mg plus doxycycline 100 mg twice a day for 7 days compared with single-dose ceftriaxone 1 g plus single-dose azithromycin 2 g for treatment of urogenital, rectal, and pharyngeal gonorrhoea: a randomised clinical trialBeatrice Bížová, Přemysl Procházka, Elka Nyčová, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 14, 2017
Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011-2015Ronza Hadad, Daniel Golparian, Amaya C Lagos, et al.
Antimicrobial Agents and Chemotherapy|January 5, 2012
Clonally related Neisseria gonorrhoeae isolates with decreased susceptibility to the extended-spectrum cephalosporin cefotaxime in Amsterdam, the NetherlandsRaymond Heymans, Sylvia M Bruisten, Daniel Golparian, et al.
Journal of Global Antimicrobial Resistance|November 18, 2020
Gonorrhoea treatment combined with population-level general cephalosporin and quinolone consumption may select for Neisseria gonorrhoeae antimicrobial resistance at the levels of NG-MAST genogroup: An ecological study in EuropeChris Kenyon, Jolein Laumen, Christophe Van Dijck, et al.
Pageof 44